EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of rapid eye movement sleep latency with multimodal biomarkers of Alzheimer's disease

Jiangli Jin iD, Jiong Chen, Clémence Cavaillès, Kristine Yaffe, Joseph Winer, Laura Stankeviciute, Brendan P Lucey, Xiao Zhou, Song Gao, Dantao Peng, Yue Leng

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.14495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Jiangli Jin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Research Center, China-Japan Friendship Hospital, Beijing, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Sleep, REM. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, NIA NIH HHS, National Health Commission of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Sleep disturbances are associated with Alzheimer's disease (AD) and Alzheimer's disease and related dementias (ADRD), but the relationship between sleep architecture, particularly rapid eye movement (REM) sleep, and AD/ADRD biomarkers remains unclear. METHODS We enrolled 128 adults (64 with Alzheimer's disease, 41 with mild cognitive impairment [MCI], and 23 with normal cognition [NC]), mean age 70.8 ± 9.6 years, 56.9% female, from a tertiary hospital in China. Participants underwent overnight polysomnography (PSG), amyloid β (Aβ) positron emission tomography (PET), and plasma biomarker analysis: phosphorylated tau at threonine 181 (p‐tau181), neurofilament light (NfL), and brain‐derived neurotrophic factor (BDNF). RESULTS After adjusting for demographics, apolipoprotein E ( APOE ) ε4 status, cognition, and comorbidities, the highest tertile of REM latency was associated with higher Aβ burden ( β = 0.08, 95% confidence interval [CI]: 0.03 to 0.13, p = 0.002), elevated p‐tau181 ( β = 0.19, 95% CI: 0.02 to 0.13, p = 0.002), and reduced BDNF levels ( β = ‐0.47, 95% CI: –0.68 to –0.13, p = 0.013), compared to the lowest tertile. DISCUSSION Prolonged REM latency may serve as a novel marker or risk factor for AD/ADRD pathogenesis. Highlights Rapid eye movement latency (REML) may be a potential marker for Alzheimer's disease and Alzheimer's disease and related dementias (AD/ADRD) pathogenesis. Prolonged REML was associated with higher amyloid beta (Aβ) burden, phosphorylated tau‐181 (p‐tau181), and lower brain‐derived neurotrophic factor (BDNF) levels. Intervention trial is needed to determine if targeting REML can modify AD/ADRD risk. Slow‐wave sleep was not associated with AD/ADRD biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionSleep, REMHumansFemaleBiomarkersMaleAgedAmyloid beta-Peptidestau ProteinsBrain-Derived Neurotrophic FactorPositron-Emission TomographyPolysomnographyMiddle AgedNeurofilament Proteins

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid betabiomarkerpolysomnographyrapid eye movement latencysleep

Substanzen

BiomarkersAmyloid beta-Peptidestau ProteinsBrain-Derived Neurotrophic FactorNeurofilament ProteinsBDNF protein, human

Autor:innen und Institutionen

  • Clinical Trial Research Center, China-Japan Friendship Hospital, Beijing, China.
  • Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.
  • Institute of Medical Technology, Peking University Health Science Center, Beijing, China.
  • Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, California, USA.
  • Department of Neurology, University of California, San Francisco, California, USA.
  • Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, California, USA.

ORCID-Profile: Jiangli Jin

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • NIA NIH HHS
  • National Health Commission of the People's Republic of China

Zitieren

APA

Jin, J., Chen, J., Cavaillès, C., Yaffe, K., Winer, J., Stankeviciute, L., Lucey, B. P., Zhou, X., Gao, S., Peng, D., & Leng, Y. (2025). Association of rapid eye movement sleep latency with multimodal biomarkers of Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14495

Vancouver

Jin J, Chen J, Cavaillès C, Yaffe K, Winer J, Stankeviciute L, et al. Association of rapid eye movement sleep latency with multimodal biomarkers of Alzheimer's disease. Alzheimer's & Dementia. 2025. doi:10.1002/alz.14495

BibTeX
@article{Jin2025,
  author = {Jin, Jiangli and Chen, Jiong and Cavaillès, Clémence and Yaffe, Kristine and Winer, Joseph and Stankeviciute, Laura and Lucey, Brendan P and Zhou, Xiao and Gao, Song and Peng, Dantao and Leng, Yue},
  title = {Association of rapid eye movement sleep latency with multimodal biomarkers of Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.14495}
}
Kostenlos starten →